This study reveals the emergence of ST697, a novel, highly drug-resistant, and virulent clone of Acinetobacter baumannii, closely related to ST2. It also identifies potent antibiotic combinations that may serve as effective alternatives to last-line monotherapy. These findings highlight the urgent need for surveillance, infection control, and targeted therapy, especially in ICU and respiratory settings, to curb the spread of this emerging clone.
Guan et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: